Edinburgh life sciences business Caritas Neuro Solutions has signed a landmark partnership agreement with an Indian company to enable it to run specialist clinical trials across south-east Asia. Caritas has teamed up with Mumbai-based biometrics company Innvocept Solutions as part of its strategy to become a world leader in mental health and neurology research. It is now able to run full service pharmaceutical and biotechnology...
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee, has made two announcements today regarding major investments and collaboration. The Company has raised US$26 million in a Series B financing round to scale up its pipeline and advance selected programmes towards clinical development. The round included participation from new investors Celgene Corporation and specialist...
Ingenza, a leading industrial biotech company, is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products. This enabling technology – the result of an initial collaboration between the two companies – was developed using Ingenza’s inABLE® suite of proprietary gene expression and DNA recombination tools. David McElroy, Chief Business Officer and Company...
Scotland’s Deputy First Minister, John Swinney, will begin a week-long visit to India on Friday to strengthen bilateral ties with a focus on trade and investment and to boost cooperation in technology and life sciences, the UK Foreign Office said Thursday. Swinney, the deputy head of the devolved Scottish government, will be joined by a delegation of senior leaders from Scotland’s higher education sector during...
The new directory called Scottish Health Research and Innovation Ecosystem launched today at the annual Life Science Scotland conference in Glasgow by Dave Tudor, Co-Chair of the Life Sciences Scotland Industry Leadership Group (LSS) as he discusses the importance of Momentum and Collaboration within the industry. This tool will facilitate essential collaboration between the NHS and other life sciences organisations in Scotland. A greatly simplified search...
Funding will be used to improve the efficiency of induced pluripotent stem cell production. Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2million project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem...